Gilead Oncology – Medical Affairs

Gilead is creating the future of oncology to help bring more life to people with cancer. We are focused on delivering transformational science, maximizing speed to the patient, and being a partner of choice.

• Discover the Gilead and Kite Oncology Pipeline
• Explore Our Highlighted Now Enrolling Clinical Trials in Oncology
• View Our Scientific Presentations at NCCN
• Watch Our Video About How Cancer Hides From the Immune System
• Discover Our Research Scholars Programs in Hematologic Malignancies and Solid Tumors
• Visit the Gilead Clinical Trials Portal
• Learn About Our Phase 2 Study Evaluating the Safety and Efficacy of Combination Therapy in Patients With Metastatic Triple-Negative Breast Cancer (ELEVATE: TNBC)
• Discover Our Phase 2 Multi-Arm Study of Combination Therapy in Patients with Solid Tumors (ELEVATE: LUNG and UROTHELIAL CANCER)
  
• Learn About Our Phase 2 Study in Patients With Metastatic Solid Tumors: NSCLC, HNSCC, SCLC, and Endometrial Cancer (TROPiCS-03)
• Discover Our Phase 2 Study of Combination Therapy in the First-Line Setting for the Treatment of Advanced or Metastatic NSCLC (EVOKE-02)
• Explore Our Phase 3 Study in Patients with Metastatic or Locally Advanced Unresectable Urothelial Carcinoma (TROPiCS-04)
• Learn About Our Multi-Cohort Phase 2 Study in Patients With Metastatic Urothelial Cancer (TROPHY-U-01)